Evidence map›Paper›PMID 34710110›Full record

ArticlePloS one2021

Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.

Ty O Easley, Zhen Ren, Byol Kim, Gregory S Karczmar, Rina F Barber, Federico D Pineda

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ty O EasleyMcKelvey School of Engineering, Washington University in St. Louis, St. Louis, Missouri, United States of America.ORCID 0000-0002-8215-2598
Zhen RenDepartment of Radiology, University of Chicago, Chicago, Illinois, United States of America.
Byol KimDepartment of Biostatistics at the University of Washington, Seattle, Washington, United States of America.
Gregory S KarczmarDepartment of Radiology, University of Chicago, Chicago, Illinois, United States of America.
Rina F BarberDepartment of Statistics, University of Chicago, Chicago, Illinois, United States of America.
Federico D PinedaDepartment of Radiology, University of Chicago, Chicago, Illinois, United States of America.
University of Chicago · USUniversity of Washington · USWashington University in St. Louis · US

Funding

Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI COX, NANCY · 2006 to 2010
$11.3M
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant TherapyU01CA142565 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARCZMAR, GREGORY S., NANDA, RITA · 2010 to 2019
$4.5M
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk AssessmentR01CA218700 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2017 to 2021
$3.0M
MRI of Early Non-invasive Rodent Mammary CancersR01CA133490 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S. · 2011 to 2015
$1.6M
High Spectral/Spatial Resolution Imaging Breast CancerR01EB003108 · NIBIB · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S · 2003 to 2006
$1.2M
A7 TESLA MAGNET/UNIVERSITY CHICAGO MRI RESEARCH SCANNERS10RR021177 · NCRR · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S · 2006 to 2006
$500k
High Spectral &Spatial Resolution MRI of Rodent TumorsR21CA089408 · NCI · UNIVERSITY OF CHICAGO · PI KARCZMAR, GREGORY S · 2002 to 2003
$366k
NCI NIH HHS P50 CA125183NCI NIH HHS R01 CA133490NCI NIH HHS R01 CA218700NCI NIH HHS R21 CA089408NCI NIH HHS U01 CA142565NCRR NIH HHS S10 RR021177NIBIB NIH HHS R01 EB003108
6 · The paper itself

Abstract

In patients with dense breasts or at high risk of breast cancer, dynamic contrast enhanced MRI (DCE-MRI) is a highly sensitive diagnostic tool. However, its specificity is highly variable and sometimes low; quantitative measurements of contrast uptake parameters may improve specificity and mitigate this issue. To improve diagnostic accuracy, data need to be captured at high spatial and temporal resolution. While many methods exist to accelerate MRI temporal resolution, not all are optimized to capture breast DCE-MRI dynamics. We propose a novel, flexible, and powerful framework for the reconstruction of highly-undersampled DCE-MRI data: enhancement-constrained acceleration (ECA). Enhancement-constrained acceleration uses an assumption of smooth enhancement at small time-scale to estimate points of smooth enhancement curves in small time intervals at each voxel. This method is tested in silico with physiologically realistic virtual phantoms, simulating state-of-the-art ultrafast acquisitions at 3.5s temporal resolution reconstructed at 0.25s temporal resolution (demo code available here). Virtual phantoms were developed from real patient data and parametrized in continuous time with arterial input function (AIF) models and lesion enhancement functions. Enhancement-constrained acceleration was compared to standard ultrafast reconstruction in estimating the bolus arrival time and initial slope of enhancement from reconstructed images. We found that the ECA method reconstructed images at 0.25s temporal resolution with no significant loss in image fidelity, a 4x reduction in the error of bolus arrival time estimation in lesions (p < 0.01) and 11x error reduction in blood vessels (p < 0.01). Our results suggest that ECA is a powerful and versatile tool for breast DCE-MRI.

Indexed as

AlgorithmsContrast MediaPhantoms, ImagingBreastBreast NeoplasmsComputer SimulationFemaleHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingContrast Media

Identifiers

PMID34710110
PMCPMC8553053
OpenAlexW3208847507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.